PARP1 and head and neck squamous cell carcinoma: Here it was suggested that the combination of PARP plus Chk1 inhibition is more effective in HPV-positive HNSCC cells, whereas the combination of PARP plus Wee1 inhibition is more effective in HPV-negative ones but the estimation was based on only one cell line per group.